Chesley Taft & Associates’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-32,100
Closed -$809K 377
2025
Q3
$809K Sell
32,100
-6,075
-16% -$153K 0.03% 235
2025
Q2
$961K Sell
38,175
-11,509
-23% -$289K 0.04% 210
2025
Q1
$1.25M Sell
49,684
-12,723
-20% -$319K 0.06% 180
2024
Q4
$1.56M Buy
62,407
+2,925
+5% +$73.3K 0.07% 160
2024
Q3
$1.49M Buy
59,482
+6,150
+12% +$153K 0.07% 161
2024
Q2
$1.33M Buy
53,332
+7,800
+17% +$193K 0.07% 165
2024
Q1
$1.13M Buy
45,532
+2,475
+6% +$61.3K 0.06% 179
2023
Q4
$1.07M Buy
43,057
+13,632
+46% +$334K 0.06% 179
2023
Q3
$717K Buy
29,425
+3,325
+13% +$81.1K 0.05% 199
2023
Q2
$636K Buy
26,100
+1,300
+5% +$31.8K 0.04% 207
2023
Q1
$608K Buy
24,800
+9,200
+59% +$225K 0.04% 209
2022
Q4
$379K Buy
+15,600
New +$378K 0.03% 239

Other funds holding IBDQ

Chesley Taft & Associates's IBDQ Position: Q4 2025 in Review

Chesley Taft & Associates sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 32,100 shares — an estimated $809K sold.

Chesley Taft & Associates first reported a position in IBDQ in Q4 2022 and held it in 12 quarters. The position peaked at $1.56M in Q4 2024. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Chesley Taft & Associates reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Chesley Taft & Associates sold 32,100 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $809K.
  • Chesley Taft & Associates first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2022 and held it in 12 quarters.
  • Chesley Taft & Associates's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $1.56M in Q4 2024.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Chesley Taft & Associates's 13F filing for Q4 2025, filed 14 Jan 2026.